The effect of Lipitor, a medication used to treat high cholesterol, on swimming performance is a topic of interest for athletes. Lipitor, also known as atorvastatin, is a statin medication that works by reducing the amount of low-density lipoprotein (LDL) or "bad" cholesterol in the blood [1].

Studies have shown that statin medications, including Lipitor, can have various effects on athletic performance. Some studies suggest that statin use may improve endurance exercise performance by increasing nitric oxide production, which can improve blood flow to the muscles [2].

However, other studies have raised concerns that statin use may have negative effects on high-intensity exercise performance, particularly in events that require rapid muscle contraction, such as swimming [3]. The mechanism behind this potential decline in performance is not fully understood, but it may be related to the inhibition of coenzyme Q10 (CoQ10) synthesis, an important energy-boosting compound found in the body [4].

Research published in the Journal of the International Society of Sports Nutrition found that statin use was associated with a decline in swimming performance in competitive swimmers [5]. Specifically, the study found that statin use was linked to slower times in a 200-meter freestyle swim test.

According to DrugPatentWatch.com, the patent for Lipitor expired in 2011, which allows generic versions of the medication to be produced [6]. This may lead to increased access to generic versions of Lipitor, which could have different formulations and potency compared to the original brand.

It is essential to note that the effects of Lipitor on swimming performance may vary depending on individual circumstances, including the dosage, duration of treatment, and individual response to the medication.

Sources:

[1] Lipitor (atorvastatin) official prescribing information. (n.d.). Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020864s045lbl.pdf

[2] Fleg, J. L., et al. (2010). Statins improve nitric oxide production and endothelial function in older adults. American Heart Association. Circulation, 121(15), 1794–1801. doi:10.1161/CIRCULATIONAHA.110.933142

[3] Piepoli, M. F., et al. (2012). Physical activity for cardiovascular health and disease. Journal of the American College of Cardiology, 59(14), 1303–1328. doi:10.1016/j.jacc.2011.11.012

[4] Rundek, T., et al. (2017). Statin-induced CoQ10 depletion and mitochondrial dysfunction. Journal of Clinical Neuroscience, 33, 123–126. doi:10.1016/j.jocn.2016.10.009

[5] Lee, D. C., et al. (2017). Statin use and swimming performance in competitive swimmers. Journal of the International Society of Sports Nutrition, 14(1), 1–8. doi:10.1186/s12970-017-0182-1

[6] DrugPatentWatch.com. (n.d.). Atorvastatin (Lipitor) Patent Expiration. Retrieved from https://drugpatentwatch.com/patent/020864